Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,400 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Immunity, 2024Meningeal lymphatic function promotes oligodendrocyte survival and brain myelination
das Neves S., Delivanoglou N., Ren Y. et al.
Target48 Mouse
npj Cardiovascular Health, 2024Using proteomics to identify the mechanisms underlying the benefits of statins on ischemic heart disease
Zhao J., Zhang J.
Olink Explore 3072/384
European Journal of Heart Failure, 2024Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy
Geissen S., Braumann S., Adler J. et al.
Olink Target 96
Nature Cancer, 2024A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma
Dimitriou F., Cheng P., Saltari A. et al.
Journal of Affective Disorders, 2024Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification
Shi Y., Bao L., Li Y. et al.
Scientific Reports, 2024Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer's disease development and vessel wall fragility
Tokuoka S., Hamano F., Kobayashi A. et al.
PLOS ONE, 2024Is there a causal relationship between resistin levels and bone mineral density, fracture occurrence? A mendelian randomization study
Xu T., Li C., Liao Y. et al.
Journal of Experimental Medicine, 2024Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer
Tsimberidou A., Alayli F., Okrah K. et al.
European Journal of Heart Failure, 2024Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort
Holm H., Magnusson M., Jujić A. et al.
Schizophrenia, 2024Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits
Li X., Wang X., Yang Y. et al.
Nature Neuroscience, 2024Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Pichet Binette A., Gaiteri C., Wennström M. et al.
Frontiers in Immunology, 2024An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
Chu Y., He X., Xue Y. et al.
Cell Host & Microbe, 2024RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding
Mitsi E., Nikolaou E., Goncalves A. et al.
Flex
Nature Communications, 2024Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Xu X., Ai L., Hu K. et al.
Frontiers in Neuroscience, 2024Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment
Ashok K., Martinez T., Sesen J. et al.
European Heart Journal, 2024Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction
Reddy Y., Melenovsky V., Asokan A. et al.
Cardiovascular Research, 2024Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis
Larsen J., Hegelund J., Pedersen M. et al.
Nature Communications, 2024Non-human primate model of long-COVID identifies immune associates of hyperglycemia
Palmer C., Perdios C., Abdel-Mohsen M. et al.
Cell Metabolism, 2024Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females
Cordeiro B., Ahn J., Gawde S. et al.
Frontiers in Immunology, 2024Comprehensive landscapes of the causal network between immunity and sarcopenia
Liu M., Wang J., Han Y. et al.
2444 publications
Items per page
361-380 of 2444 publications